Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medicap Compounding Center is a specialized compounding pharmacy network based in Iowa, operating key facilities in Coralville and Waterloo. Formerly operating as NuCara's compounding pharmacy division, the business was rebranded to Medicap Compounding Center following its acquisition by OneroRx in April 2026. The center specializes in preparing customized, patient-specific medications, including dermatological treatments, hormone replacement therapies, pain management formulations, and pediatric and veterinary medications. Notably, it is the exclusive licensed producer of WartPEEL, a patented compounded topical gel containing salicylic acid and 5-fluorouracil used for the treatment of warts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medicap Compounding Center.